SG11202109872SA - Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancers - Google Patents
Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancersInfo
- Publication number
- SG11202109872SA SG11202109872SA SG11202109872SA SG11202109872SA SG 11202109872S A SG11202109872S A SG 11202109872SA SG 11202109872S A SG11202109872S A SG 11202109872SA SG 11202109872S A SG11202109872S A SG 11202109872SA
- Authority
- SG
- Singapore
- Prior art keywords
- diseases
- cancers
- bacterium
- prevention
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816539P | 2019-03-11 | 2019-03-11 | |
| FR1902437A FR3093642A1 (en) | 2019-03-11 | 2019-03-11 | Bacteria of the Christensenellaceae family in the prevention and / or treatment of chronic inflammatory diseases and / or cancers |
| FR1908384A FR3099054A1 (en) | 2019-07-24 | 2019-07-24 | Christensenella strain for use in the treatment and prevention of gastrointestinal inflammation |
| PCT/EP2020/056565 WO2020182916A1 (en) | 2019-03-11 | 2020-03-11 | Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202109872SA true SG11202109872SA (en) | 2021-10-28 |
Family
ID=77922950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202109872S SG11202109872SA (en) | 2019-03-11 | 2020-03-11 | Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancers |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR20210141541A (en) |
| CN (1) | CN113631174A (en) |
| AU (1) | AU2020235358A1 (en) |
| CA (1) | CA3132239A1 (en) |
| SG (1) | SG11202109872SA (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113975301B (en) * | 2021-11-24 | 2023-06-30 | 暨南大学 | Probiotic preparation for improving sperm motility and application thereof |
| CN114159477B (en) * | 2021-11-24 | 2023-06-30 | 暨南大学 | Probiotic preparation for improving enteritis-induced male reproductive injury and application thereof |
| CN116919994B (en) * | 2023-09-15 | 2023-12-08 | 中国农业大学 | Application of Klebsiella minutissima Teng Senshi bacteria in preparation of medicine for treating polycystic ovary syndrome |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3034317B1 (en) * | 2015-03-31 | 2018-09-14 | International Nutrition Research Company | COMPOSITION FOR THE TREATMENT OF A PATHOGENIC METABOLIC STATE OF THE INTESTINAL MICROBIOTE AND DERIVED DISEASES |
| WO2016156527A1 (en) * | 2015-03-31 | 2016-10-06 | International Nutrition Research Company | Composition for the treatment of a pathogenic metabolic state of the intestinal microbiota and of derived diseases |
| CN107771083A (en) * | 2015-04-23 | 2018-03-06 | 卡莱多生物科技有限公司 | Glycan therapeutic agent and treatment method |
| WO2017060698A1 (en) * | 2015-10-05 | 2017-04-13 | Liam O'mahony | Use of akkermansia muciniphila for treating inflammatory conditions |
| US11090342B2 (en) * | 2016-04-11 | 2021-08-17 | President And Fellows Of Harvard College | Probiotic formulations for improving athletic performance |
| FR3063646B1 (en) * | 2017-03-10 | 2021-07-30 | International Nutrition Res Company | BACTERIA SPECIFIC FOR THEIR USE AS A MEDICINAL PRODUCT, IN PARTICULAR FOR THE CONTROL OF OVERWEIGHT, OBESITY, CARDIOMETABOLIC DISEASES AND INFLAMMATORY DISEASES OF THE INTESTINE |
-
2020
- 2020-03-11 AU AU2020235358A patent/AU2020235358A1/en active Pending
- 2020-03-11 SG SG11202109872S patent/SG11202109872SA/en unknown
- 2020-03-11 KR KR1020217032626A patent/KR20210141541A/en unknown
- 2020-03-11 CA CA3132239A patent/CA3132239A1/en active Pending
- 2020-03-11 CN CN202080024667.9A patent/CN113631174A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210141541A (en) | 2021-11-23 |
| AU2020235358A1 (en) | 2021-10-07 |
| CN113631174A (en) | 2021-11-09 |
| CA3132239A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286182A (en) | Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancers | |
| IL271230A (en) | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | |
| EP3600281A4 (en) | Combination therapy for the treatment or prevention of tumours | |
| SG11202109872SA (en) | Bacterium of the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or inflammatory gastrointestinal diseases and/or cancers | |
| ZA201807098B (en) | Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract | |
| IL279347A (en) | Gremlin-1 antagonist for the prevention and treatment of cancer | |
| MX2021003224A (en) | Probiotic combination for treatment of inflammatory-related gastrointestinal disorders. | |
| EP3749342A4 (en) | Bacteriophage for treatment and prevention of bacteria-associated cancers | |
| IL279634A (en) | Compositions and methods for the treatment and prevention of neurological disorders | |
| EP3258927B8 (en) | Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract | |
| EP3600304A4 (en) | Berberine alkaloids in the prevention and/or treatment of intestinal disease | |
| IL282904A (en) | Therapeutic microbiota for the treatment and/or prevention of dysbiosis | |
| EP3897601A4 (en) | Treatment of gastrointestinal disorders and symptoms thereof | |
| PT3911347T (en) | Composition for the treatment and/or prevention of lower urinary tract symptoms | |
| GB201904374D0 (en) | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders | |
| GB201712459D0 (en) | Treatment or prevention of gastrointestinal dysbiosis | |
| AU2018903823A0 (en) | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
| IL285297A (en) | Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal system | |
| AU2019901175A0 (en) | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
| GB201815694D0 (en) | Prevention and treatment of cancer | |
| GB201809946D0 (en) | Prevention and treatment of cancer | |
| FI3829535T3 (en) | Compositions for the prevention and treatment of cutaneous affections | |
| EP3781688A4 (en) | Tnf-targeting aptamers and uses thereof for treatment or diagnosing tnf-related inflammatory diseases | |
| GB201718925D0 (en) | Pharmaceutical composition suitable for gastric cancer treatment and/or prevention | |
| AU2017903261A0 (en) | Berberine alkaloids in the prevention and/or treatment of intestinal disease |